Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-18

Clinical Trial Update: Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 [NA]

View source ↗

Summary

This clinical trial evaluates whether hepatotoxicity and neurotoxicity from oxaliplatin correlate with blood levels of HMGB1 in patients with pancreatic, esopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eloxatin (oxaliplatin)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma | NA | Status: RECRUITING